Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.71

+0.4%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: zeta1961	1/31/2007 10:27:19 PM
	Read Replies (1) of 52153

Back to biotech valuations-g- I just caught this on Nightly Business Report on PBS STREET CRITIQUE: Hilary Kramer, Market Strategist and Personal Finance Columnist at AOL.com, will provide her stock market analysis in an interview with NBR Anchor Paul Kangas http://www.pbs.org/nbr/site/onair/upcoming/upcoming/ She mentioned: Medivations(MDV: AMEX).. Alzheimer's candidate CADX which is making an intravenous formulation of Tylenol<wow> MDCO..heparin competitor? SGEN..oncology She just gave a one sentence blurb on each and disclosed owning only MDV..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next